Barnett-Tapia C, Cortes Vicente E, Pascuzzi RM, Utsugisawa K, et al. Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study. J Neurol 2025;272:752.
PMID: 41205003